Novartis Japan Told to Improve Business over Delayed Reporting of Nearly 5,500 ADRs

The Ministry of Health, Labor and Welfare (MHLW) on November 13 imposed yet another administrative penalty on Novartis Pharma over delays in side effect reporting - this time spanning 5,475 adverse drug reaction (ADR) cases across 57 compounds. The MHLW...read more